Continuing Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Advanced Breast Cancer: A Meta-Analysis †.
- Published in:
- Cancers, 2025, v. 17, n. 10, p. 1609, doi. 10.3390/cancers17101609
- By:
- Publication type:
- Article
Works matching AU Wygoda, Yael Berner
Results: 5
1
2
Breast Cancer with Low Recurrence Score on Oncotype DX<sup>©</sup>: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 2, p. 441, doi. 10.1007/s40487-022-00202-7
- By:
- Publication type:
- Article
3
Palliative care: needs of advanced breast cancer patients.
- Published in:
- Breast Cancer: Targets & Therapy, 2018, v. 10, p. 231, doi. 10.2147/BCTT.S160462
- By:
- Publication type:
- Article
4
Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor.
- Published in:
- Breast Cancer Research & Treatment, 2025, v. 210, n. 2, p. 405, doi. 10.1007/s10549-024-07578-2
- By:
- Publication type:
- Article
5
First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 954, doi. 10.1159/000533519
- By:
- Publication type:
- Article